Progressive Muscular Dystrophy in α-Sarcoglycan–deficient Mice

Overview of attention for article published in Journal of Cell Biology, September 1998

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (80th percentile)
Good Attention Score compared to outputs of the same age and source (71st percentile)

Mentioned by

patent: 33 patents

Readers on

mendeley: 151 Mendeley

So far, Altmetric has seen 33 patents that reference this research output.

FIBRONECTIN BASED SCAFFOLD DOMAIN PROTEINS THAT BIND TO MYOSTATIN

Application EP-4397675-A2

European Patent Office

10 Jul 2024

FIBRONECTIN BASED SCAFFOLD DOMAIN PROTEINS THAT BIND TO MYOSTATIN

Application EP-3835310-A1

European Patent Office

16 Jun 2021

Compositions and methods for correcting limb girdle muscular dystrophy type 2C using exon…

Grant US-10801029-B2

United States of America

13 Oct 2020

Methods of treating muscular dystrophy

Grant US-10537553-B2

United States of America

21 Jan 2020

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 29 additional patents.